Effect of coadministration of ketoconazole, a strong CYP3A4 inhibitor, on pharmacokinetics and tolerability of motesanib diphosphate (AMG 706) in patients with advanced solid tumors.
Invest New Drugs
; 26(5): 455-62, 2008 Oct.
Article
in En
| MEDLINE
| ID: mdl-18574557
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Niacinamide
/
Cytochrome P-450 CYP3A Inhibitors
/
Indoles
/
Ketoconazole
/
Neoplasms
Type of study:
Clinical_trials
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Invest New Drugs
Year:
2008
Document type:
Article
Affiliation country:
United States